Loncar Funds is a financial company that specializes in creating and managing thematic investment products and indexes that track innovation within the biopharmaceutical industry. The firm's mission is to make biotech investing more accessible to a broader range of investors. Their two primary products are the Loncar Cancer Immunotherapy ETF (Nasdaq: CNCR), which tracks a basket of companies developing cancer immunotherapy treatments, and the Loncar China BioPharma ETF (Nasdaq: CHNA), which focuses on companies leading China's biotechnology revolution. The firm is managed by Loncar Investments, LLC, a registered investment adviser.

Founded in

United States